Does Pre-operative Gastric Ultrasound Influence Anaesthetic Decision-Making in Chronic Pain Patie… (NCT07537582) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Does Pre-operative Gastric Ultrasound Influence Anaesthetic Decision-Making in Chronic Pain Patients? A Prospective Observational Cohort.
United Arab Emirates140 participantsStarted 2026-04
Plain-language summary
Gastric POCUS has been validated and shown to be an accurate diagnostic tool in both healthy individuals and medically complex patient populations. Regional anaesthesiologists and pain management physicians frequently provide sedation or anaesthetic care for medically complex patients who fall outside the limited applicability of existing fasting guidelines, including patients with chronic pain, poor acute-on-chronic pain control, and those receiving acute or chronic opioid therapy. These patients are at risk of delayed gastric emptying and may therefore benefit from additional pre-procedural assessment using gastric ultrasound prior to elective interventions
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria: Patients were eligible for inclusion if they met all of the following criteria:
* Age ≥18 years
* Scheduled for elective chronic pain interventional procedures under procedural sedation
* Adherence to standard preoperative fasting guidelines (≥6 hours for clear fluids and ≥8 hours for solids)
* Presence of at least one clinical factor associated with delayed gastric emptying or increased risk of pulmonary aspiration, including:
* Chronic opioid use (≥2 weeks)
* Acute opioid administration within 24 hours prior to the procedure
* Poorly controlled acute-on-chronic pain
* Diabetes mellitus without established autonomic neuropathy
* Symptoms of gastroesophageal reflux
* Reduced functional mobility
* ASA physical status II-III
Exclusion Criteria: Patients will be excluded if any of the following present:
* Age \<18 years
* Previous gastric or esophageal surgery
* Known pregnancy
* Known hiatal hernia
* Severe neurological disorders affecting swallowing or gastric motility
* Established autonomic neuropathy affecting gastric emptying (e.g. advanced diabetic gastroparesis)
* Morbid obesity (body mass index ≥35 kg·m-²), due to known limitations in gastric ultrasound image acquisition and reduced validity of volume estimation models
* Inability to provide informed consent
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
The proportion of patients in whom pre-procedural gastric ultrasound resulted in a change to the pre-defined anesthetic management plan.
Timeframe: 1- 2 hours
Trial details
NCT IDNCT07537582
SponsorDanat Al Emarat Hospital
Sponsor typeOTHER
Study typeOBSERVATIONAL
Primary completion2027-04
Contact for this trial
JINAN JAMEEL AL ALOOSI, CONSULTANT ANESTHESIOLOGIST